ARTICLE | Clinical News
Aventis to start pivotal AAT trial
September 17, 2001 7:00 AM UTC
AVE will begin in the first quarter of 2002 an international pivotal trial of inhaleable human alpha1-antitrypsin ( AAT) to treat hereditary emphysema. The therapy uses Inhance pulmonary delivery tech...